Dagenais, G R, Rydén, L, Leiter, L A, Lakshmanan, M, Dyal, L, Probstfield, J L, Atisso, C M, Shaw, J E, Conget, I, Cushman, W C, Lopez-Jaramillo, P, Lanas, F, Munoz, E G C, Pirags, V, Pogosova, N, Basile, J, Sheu, W H H, Temelkova-Kurktschiev, T, Raubenheimer, P J, Keltai, M, Hall, S, Pais, P, Colhoun, H M, Riddle, M C & Gerstein, H C 2020, ' Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail : a post hoc analysis ', Cardiovascular diabetology, vol. 19, no. 1, pp. 199 . https://doi.org/10.1186/s12933-020-01179-1 Cardiovascular Diabetology